143 related articles for article (PubMed ID: 15163265)
1. Diabetic ketoacidosis, neuroleptic malignant syndrome, and myocardial infarction in a patient taking risperidone and lithium carbonate.
Ananth J; Johnson KM; Levander EM; Harry JL
J Clin Psychiatry; 2004 May; 65(5):724. PubMed ID: 15163265
[No Abstract] [Full Text] [Related]
2. Effects of concomitant risperidone and lithium treatment.
Swanson CL; Price WA; McEvoy JP
Am J Psychiatry; 1995 Jul; 152(7):1096. PubMed ID: 7540798
[No Abstract] [Full Text] [Related]
3. Risperidone-associated transient diabetic ketoacidosis and diabetes mellitus type 1 in a patient treated with valproate and lithium.
Mithat B; Alpaslan T; Bulent C; Cengiz T
Pharmacopsychiatry; 2005 Mar; 38(2):105-6. PubMed ID: 15744639
[TBL] [Abstract][Full Text] [Related]
4. [Neuroleptic malignant syndrome in users of risperidone].
Vorel SK; Bos F; Vorel-Havelkova E; Brombacher PJ
Ned Tijdschr Geneeskd; 2005 Jan; 149(3):159-60; author reply 160. PubMed ID: 15693596
[No Abstract] [Full Text] [Related]
5. [Neuroleptic malignant syndrome in users of risperidone].
Kroon JG
Ned Tijdschr Geneeskd; 2005 Jan; 149(3):157-8; author reply 158. PubMed ID: 15693594
[No Abstract] [Full Text] [Related]
6. [Neuroleptic malignant syndrome in users of risperidone].
van Bemmel T; Westendorp RG
Ned Tijdschr Geneeskd; 2005 Mar; 149(11):608; author reply 608. PubMed ID: 15799646
[No Abstract] [Full Text] [Related]
7. [Neuroleptic malignant syndrome in users of risperidone].
Bonte-Mineur F; Geerlings CJ; Rietveld AP
Ned Tijdschr Geneeskd; 2005 Jan; 149(3):158-9; author reply 159. PubMed ID: 15693595
[No Abstract] [Full Text] [Related]
8. Neuroleptic malignant syndrome with risperidone.
Gleason PP; Conigliaro RL
Pharmacotherapy; 1997; 17(3):617-21. PubMed ID: 9165568
[TBL] [Abstract][Full Text] [Related]
9. Neuroleptic malignant syndrome with risperidone.
Levin GM; Lazowick AL; Powell HS
J Clin Psychopharmacol; 1996 Apr; 16(2):192-3. PubMed ID: 8690838
[No Abstract] [Full Text] [Related]
10. [Neuroleptic malignant syndrome in users of risperidone].
van Waarde JA; Kuiper J; Verwey B
Ned Tijdschr Geneeskd; 2005 Jan; 149(3):156-7; author reply 157. PubMed ID: 15693593
[No Abstract] [Full Text] [Related]
11. The role of CYP2D6 and TaqI A polymorphisms in malignant neuroleptic syndrome: two case reports with three episodes.
Zivković M; Mihaljević-Peles A; Sagud M; Silić A; Mihanović M
Psychiatr Danub; 2010 Mar; 22(1):112-6. PubMed ID: 20305604
[TBL] [Abstract][Full Text] [Related]
12. Risperidone, neuroleptic malignant syndrome and probable dementia with Lewy bodies.
Sechi G; Agnetti V; Masuri R; Deiana GA; Pugliatti M; Paulus KS; Rosati G
Prog Neuropsychopharmacol Biol Psychiatry; 2000 Aug; 24(6):1043-51. PubMed ID: 11041543
[TBL] [Abstract][Full Text] [Related]
13. Novel antipsychotics and neuroleptic malignant syndrome.
Buckley P
Psychiatr Serv; 1996 Apr; 47(4):431. PubMed ID: 8689381
[No Abstract] [Full Text] [Related]
14. Encephalopathy with combined lithium-risperidone administration.
Boora K; Xu J; Hyatt J
Acta Psychiatr Scand; 2008 May; 117(5):394-5; discussion 396. PubMed ID: 18331580
[TBL] [Abstract][Full Text] [Related]
15. Diabetic ketoacidosis associated with risperidone treatment?
Croarkin PE; Jacobs KM; Bain BK
Psychosomatics; 2000; 41(4):369-70. PubMed ID: 10906363
[No Abstract] [Full Text] [Related]
16. Neuroleptic malignant syndrome caused by combination of risperidone and lithium in a patient with multiple medical comorbidities.
Kosehasanogullari SG; Akdede B; Akvardar Y; Akan M; Tunca Z
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1147-8. PubMed ID: 17513032
[No Abstract] [Full Text] [Related]
17. Atypical neuroleptic malignant syndrome associated with risperidone treatment in two adolescents.
Zalsman G; Lewis R; Konas S; Loebstein O; Goldberg P; Burguillo F; Nahshoni E; Munitz H
Int J Adolesc Med Health; 2004; 16(2):179-82. PubMed ID: 15266995
[TBL] [Abstract][Full Text] [Related]
18. Risperidone and NMS?
Murray S; Haller E
Psychiatr Serv; 1995 Sep; 46(9):951. PubMed ID: 7583513
[No Abstract] [Full Text] [Related]
19. Potentiating effect of fluphenazine decanoate and risperidone on development of neuroleptic malignant syndrome.
Liu PY; Wu PC; Chen CY; Chen YC
Gen Hosp Psychiatry; 2011; 33(1):84.e5-7. PubMed ID: 21353143
[TBL] [Abstract][Full Text] [Related]
20. New-onset diabetic ketoacidosis in a schizophrenic patient with multiple autoimmune disease during treatment with risperidone.
Sato Y; Yasui-Furukori N; Kaneko S; Moriyama T
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):577-8. PubMed ID: 17919798
[No Abstract] [Full Text] [Related]
[Next] [New Search]